David Bouchey
Stock Analyst at Aegis Capital
(n/a)
# 4,720
Out of 5,131 analysts
8
Total ratings
11.11%
Success rate
-46.33%
Average return
Main Sectors:
Stocks Rated by David Bouchey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SBFM Sunshine Biopharma | Reiterates: Buy | $7 | $1.33 | +426.32% | 3 | Oct 8, 2025 | |
| AEON AEON Biopharma | Reiterates: Buy | $7.2 | $1.08 | +566.67% | 1 | Oct 8, 2025 | |
| STSS Sharps Technology | Initiates: Buy | $105,600 | $1.89 | +5,587,201.59% | 1 | May 9, 2023 | |
| IINN Inspira Technologies Oxy B.H.N. | Maintains: Buy | $10 → $13 | $0.93 | +1,305.25% | 1 | Jan 25, 2023 | |
| RMTI Rockwell Medical | Downgrades: Outperform | $121 | $0.94 | +12,806.67% | 2 | Oct 19, 2018 |
Sunshine Biopharma
Oct 8, 2025
Reiterates: Buy
Price Target: $7
Current: $1.33
Upside: +426.32%
AEON Biopharma
Oct 8, 2025
Reiterates: Buy
Price Target: $7.2
Current: $1.08
Upside: +566.67%
Sharps Technology
May 9, 2023
Initiates: Buy
Price Target: $105,600
Current: $1.89
Upside: +5,587,201.59%
Inspira Technologies Oxy B.H.N.
Jan 25, 2023
Maintains: Buy
Price Target: $10 → $13
Current: $0.93
Upside: +1,305.25%
Rockwell Medical
Oct 19, 2018
Downgrades: Outperform
Price Target: $121
Current: $0.94
Upside: +12,806.67%